CBD clinical trials: pipeline by phase and status
Every trial in this library's ClinicalTrials.gov slice that names CBD: 40 registered studies, grouped by phase and by recruitment status. For the published research, see the CBD research page.
The pipeline at a glance
| Phase | Trials |
|---|---|
| Early phase 1 | 2 |
| Phase 1 | 3 |
| Phase 1/2 | 4 |
| Phase 2 | 18 |
| Phase 2/3 | 4 |
| Phase 3 | 3 |
| Not applicable | 3 |
| Unspecified | 3 |
| Status | Trials |
|---|---|
| Recruiting or planned | 15 |
| Active, not recruiting | 2 |
| Completed | 12 |
| Stopped | 9 |
| Unknown or other | 2 |
7,157 participants across the 40 trials that report enrollment. The earliest registered start is 2013, and 8 trials started in the last two years.
Most active sponsors
- Mclean Hospital 5 trials
- University of Colorado, Denver 4 trials
- University of Colorado, Boulder 3 trials
- Johns Hopkins University 2 trials
- McMaster University 2 trials
All 40 trials
Most advanced phase first, and within each phase the most recent start date first.
Phase 3 3 trials
-
Recruiting Phase 3 360 participants University of British Columbia Started 2023
Bipolar Disorder
-
Unknown status Phase 3 50 participants McMaster University Started 2021
Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia
-
Withdrawn Phase 3 0 participants McMaster University Started 2021
Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia
Phase 2/3 4 trials
-
Recruiting Phase 2/3 105 participants Johns Hopkins University Started 2026
Alcohol Use Disorder (AUD), Withdrawal From Addictive Substance; Detoxification, Craving
-
Recruiting Phase 2/3 180 participants University of Colorado, Denver Started 2023
Alcohol Use Disorder
-
Suspended Phase 2/3 200 participants University of Texas at Austin Started 2020
Anxiety Depression, Alcohol Abuse, Substance Abuse, Anger
-
Terminated Phase 2/3 36 participants Hospital de Clinicas de Porto Alegre Started 2017
Bipolar Disorder, Bipolar Depression, Bipolar Affective Disorder
Phase 2 18 trials
-
Recruiting Phase 2 120 participants University of Colorado, Denver Started 2024
Cannabis Use Disorder
-
Withdrawn Phase 2 0 participants Dr. Paul Lyons Started 2024
Post-traumatic Epilepsy
-
Recruiting Phase 2 120 participants University of California, Los Angeles Started 2024
Tobacco Use Disorder, Tobacco Smoking, Tobacco Dependence
-
Terminated Phase 2 10 participants Hôpital le Vinatier Started 2024
Alcohol Use Disorder
-
Recruiting Phase 2 185 participants University of Colorado, Boulder Started 2024
Sleep, Anxiety, Depression, Pain
-
Recruiting Phase 2 165 participants University of Colorado, Boulder Started 2024
Cannabis Use Disorder
-
Recruiting Phase 2 385 participants University of Colorado, Boulder Started 2024
Sleep, Anxiety, Depression, Pain
-
Recruiting Phase 2 210 participants Assistance Publique - Hôpitaux de Paris Started 2024
Severe Alcohol Use Disorder (DSM 5)
-
Terminated Phase 2 2 participants Mclean Hospital Started 2024
Glioblastoma
-
Completed Phase 2 27 participants Medical University of Warsaw Started 2023
Parkinson's Disease (PD)
-
Recruiting Phase 2 25 participants Mclean Hospital Started 2023
Bipolar Disorder
-
Completed Phase 2 63 participants University of California, San Diego Started 2023
Social Anxiety, Social Anxiety Disorder
-
Completed Phase 2 126 participants University of Colorado, Denver Started 2022
Opioid Use Disorder
-
Completed Phase 2 45 participants University of Colorado, Denver Started 2021
Alcohol Use Disorder
-
Terminated Phase 2 15 participants Mclean Hospital Started 2021
Anxiety
-
Withdrawn Phase 2 0 participants CB2 Insights Started 2020
Anxiety
-
Completed Phase 2 80 participants Multidisciplinary Association for Psychedelic Studies Started 2017
Posttraumatic Stress Disorder
-
Unknown status Phase 2 5 participants The University of New South Wales Started 2014
Cannabis Use Disorder
Phase 1/2 4 trials
-
Not yet recruiting Phase 1/2 280 participants Leslie Lundahl Started 2026
PTSD, Post Traumatic Stress Disorder, Suicide, Cannabis Use
-
Recruiting Phase 1/2 120 participants Universidade do Sul de Santa Catarina Started 2026
Major Depressive Disorder (MDD), Treatment-resistant Depression (TRD)
-
Recruiting Phase 1/2 500 participants Wayne State University Started 2025
Post Traumatic Stress Disorder, Cannabis Use, Suicide, Veterans
-
Completed Phase 1/2 95 participants NYU Langone Health Started 2019
Alcohol Use Disorder, Post Traumatic Stress Disorder
Phase 1 3 trials
-
Recruiting Phase 1 50 participants Johns Hopkins University Started 2022
Tobacco Use, Tobacco Smoking, Tobacco Dependence, Tobacco Use Disorder
-
Completed Phase 1 10 participants Mclean Hospital Started 2016
Cannabis Use Disorder
-
Withdrawn Phase 1 0 participants New York State Psychiatric Institute
Chronic Pain
Early phase 1 2 trials
-
Active, not recruiting Early Phase 1 40 participants University of California, San Diego Started 2022
Anorexia Nervosa
-
Active, not recruiting Early Phase 1 12 participants Mclean Hospital Started 2021
Alzheimer Disease, Anxiety, Agitation,Psychomotor, Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Not applicable 3 trials
-
Completed 36 participants Prima CBD Started 2022
Anxiety, Fear, Stress, Low Mood
-
Completed 48 participants University College, London Started 2019
Cannabis, Cannabis Intoxication, Cannabis Use, Cannabis Dependence
-
Completed 38 participants University of Chicago Started 2013
Drug Addiction
Unspecified 3 trials
-
Enrolling by invitation 384 participants Santa Catarina Federal University Started 2026
Chronic Pain, Depression Disorders, Anxiety Disorders, Quality of Life
-
Completed 3,000 participants Radicle Science Started 2021
Pain, Sleep Disturbance, Anxiety
-
Completed 30 participants Formula30A LLC Started 2020
Generalized Anxiety Disorder
Data from ClinicalTrials.gov (opens in new tab), refreshed daily. Browse all clinical trials.